Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS).
about
Teriparatide for osteoporosis: importance of the full courseAnabolic treatment for osteoporosis: teriparatide.Real-world effectiveness of daily teriparatide in Japanese patients with osteoporosis at high risk for fracture: final results from the 24-month Japan Fracture Observational Study (JFOS).Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach.
P2860
Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fracture Rate, Quality of Life ...... o Observational Study (ExFOS).
@en
Fracture Rate, Quality of Life ...... o Observational Study (ExFOS).
@nl
type
label
Fracture Rate, Quality of Life ...... o Observational Study (ExFOS).
@en
Fracture Rate, Quality of Life ...... o Observational Study (ExFOS).
@nl
prefLabel
Fracture Rate, Quality of Life ...... o Observational Study (ExFOS).
@en
Fracture Rate, Quality of Life ...... o Observational Study (ExFOS).
@nl
P2093
P2860
P1476
Fracture Rate, Quality of Life ...... o Observational Study (ExFOS).
@en
P2093
Bente L Langdahl
Claude-Laurent Benhamou
Eric Lespessailles
Erik Lindh
Fernando Marin
George Kapetanos
Helmut Petto
Tatjana Nikolic
Thomas Moll
Tomaz Kocjan
P2860
P2888
P304
P356
10.1007/S00223-016-0143-5
P407
P577
2016-04-30T00:00:00Z